NextCure, Inc.
NXTCNasdaqCIK 1661059HealthcareFiscal year ends Dec 31
Reports and events: 116 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2516:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-110971 |
| 2026-09-0316:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-105057 |
| 2026-08-0616:25 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-092050 |
| 2026-08-0616:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092025 |
| 2026-07-1407:00 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-083326 |
| 2026-06-2508:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-077546 |
| 2026-06-0108:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-068604 |
| 2026-05-0716:25 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057187 |
| 2026-05-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057171 |
| 2026-04-2416:15 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001104659-26-048591 |
| 2026-03-0516:26 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-024137 |
| 2026-03-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-024121 |
| 2026-03-0506:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-023741 |
| 2026-01-2307:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006021 |
| 2025-12-1917:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-123305 |
| 2025-11-1708:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112975 |
| 2025-11-0516:25 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107036 |
| 2025-11-0516:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107008 |
| 2025-08-2516:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-011752 |
| 2025-08-0716:27 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010782 |
| 2025-08-0716:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010774 |
| 2025-07-1407:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-25-009214 |
| 2025-07-1009:00 ET | 8-K | 8.01 Other events | 0001558370-25-009163 |
| 2025-06-2309:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-008789 |
| 2025-06-1607:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-008633 |
| 2025-05-0116:25 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006111 |
| 2025-05-0116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006106 |
| 2025-04-2506:04 ET | DEF 14A | Proxy statementPeriod 2025-06-20 | 0001104659-25-038880 |
| 2025-04-1008:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-004651 |
| 2025-03-0616:26 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002402 |
| 2025-03-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002396 |
| 2025-02-0316:10 ET | 8-K | 3.01 Delisting notice | 0001558370-25-000603 |
| 2025-01-1008:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000099 |
| 2024-12-1008:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-016108 |
| 2024-12-0507:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-016026 |
| 2024-11-0816:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-015060 |
| 2024-11-0716:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014869 |
| 2024-11-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014866 |
| 2024-08-0116:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-010605 |
| 2024-08-0116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-010598 |
| 2024-06-2116:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-009401 |
| 2024-06-1816:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-009282 |
| 2024-05-0216:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-006551 |
| 2024-05-0216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-006543 |
| 2024-04-2616:06 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001104659-24-052922 |
| 2024-03-2109:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003672 |
| 2024-03-2109:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-003671 |
| 2024-03-0816:34 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000274 |
| 2023-12-1407:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-019766 |
| 2023-11-0216:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017429 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 19:37 ET. Listed shows no prices and gives no investment advice.